BioXcel Therapeutics Statistics
Total Valuation
BTAI has a market cap or net worth of $100.36 million. The enterprise value is $136.18 million.
| Market Cap | 100.36M |
| Enterprise Value | 136.18M |
Important Dates
The next estimated earnings date is Monday, May 6, 2024, before market open.
| Earnings Date | May 6, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
BTAI has 37.03 million shares outstanding. The number of shares has increased by 3.98% in one year.
| Shares Outstanding | 37.03M |
| Shares Change (YoY) | +3.98% |
| Shares Change (QoQ) | +0.58% |
| Owned by Insiders (%) | 27.01% |
| Owned by Institutions (%) | 28.51% |
| Float | 21.69M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 72.73 |
| Forward PS | 29.24 |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 98.68 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.65
| Current Ratio | 2.65 |
| Quick Ratio | 2.39 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -12.45 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -144.90% |
| Return on Capital (ROIC) | -385.77% |
| Revenue Per Employee | $18,649 |
| Profits Per Employee | -$2.42M |
| Employee Count | 74 |
| Asset Turnover | 0.01 |
| Inventory Turnover | 0.63 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -88.17% in the last 52 weeks. The beta is 0.39, so BTAI's price volatility has been lower than the market average.
| Beta (1Y) | 0.39 |
| 52-Week Price Change | -88.17% |
| 50-Day Moving Average | 2.90 |
| 200-Day Moving Average | 3.99 |
| Relative Strength Index (RSI) | 47.50 |
| Average Volume (30 Days) | 1,551,050 |
Short Selling Information
The latest short interest is 2.49 million, so 6.73% of the outstanding shares have been sold short.
| Short Interest | 2.49M |
| Short Previous Month | 3.14M |
| Short % of Shares Out | 6.73% |
| Short % of Float | 11.48% |
| Short Ratio (days to cover) | 3.65 |
Income Statement
In the last 12 months, BTAI had revenue of $1.38 million and -$179.05 million in losses. Loss per share was -$6.15.
| Revenue | 1.38M |
| Gross Profit | 120,000 |
| Operating Income | -171.78M |
| Pretax Income | -179.05M |
| Net Income | -179.05M |
| EBITDA | -165.42M |
| EBIT | -165.74M |
| Loss Per Share | -$6.15 |
Balance Sheet
The company has $65.22 million in cash and $101.04 million in debt, giving a net cash position of -$35.82 million or -$0.97 per share.
| Cash & Cash Equivalents | 65.22M |
| Total Debt | 101.04M |
| Net Cash | -35.82M |
| Net Cash Per Share | -$0.97 |
| Equity / Book Value | -56.51M |
| Book Value Per Share | -1.53 |
| Working Capital | 44.88M |
Cash Flow
In the last 12 months, operating cash flow was -$155.01 million and capital expenditures -$20,000, giving a free cash flow of -$155.03 million.
| Operating Cash Flow | -155.01M |
| Capital Expenditures | -20,000 |
| Free Cash Flow | -155.03M |
| FCF Per Share | -$5.32 |
Margins
Gross margin is 8.70%, with operating and profit margins of -12,447.97% and -12,974.86%.
| Gross Margin | 8.70% |
| Operating Margin | -12,447.97% |
| Pretax Margin | -12,974.86% |
| Profit Margin | -12,974.86% |
| EBITDA Margin | -11,987.03% |
| EBIT Margin | -12,010.07% |
| FCF Margin | -11,233.77% |
Dividends & Yields
BTAI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.98% |
| Shareholder Yield | -3.98% |
| Earnings Yield | -178.40% |
| FCF Yield | -154.46% |
Analyst Forecast
The average price target for BTAI is $6.00, which is 121.40% higher than the current price. The consensus rating is "Buy".
| Price Target | $6.00 |
| Price Target Difference | 121.40% |
| Analyst Consensus | Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (5Y) | 158.92% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BTAI has an Altman Z-Score of -17.43 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -17.43 |
| Piotroski F-Score | 2 |